Sanofi tells Philippines no refund for used dengue vaccine that could worsen disease symptoms

Manila, Philippines – French pharmaceutical giant Sanofi Pasteur on Monday (Feb 5) declined to refund the Philippines for used vials of Dengvaxia, its controversial vaccine against the mosquito-borne dengue disease, worth about 1.6 billion pesos (S$40 million). The French pharmaceutical Read More …